RECEF
Price:
$0.22
Market Cap:
$138.81M
Recce Pharmaceuticals Ltd is a biotechnology firm dedicated to the discovery, development, and commercialization of cutting-edge synthetic anti-infective treatments. The company's operations span major markets, including Australia, the United States, and the United Kingdom. Its primary drug candidate, RECCE 327, is engineered to combat severe blood infections and sepsis caused by E. coli and S. aureus bacteria, critically, even their antibiotic-resistant 'superbug' forms. In addition to RECCE 327, the company's pipeline includes RECCE 529, another synthetic anti-infective being developed for viral infections, and RECCE 435, a synthetic polymer anti-infective. Founded in 2007, the company ori...[Read more]
Industry
Biotechnology
IPO Date
2022-08-12
Stock Exchange
OTC
Ticker
RECEF
According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -3.67. This represents a change of 36.94% compared to the average of -2.68 of the last 4 quarters.
The mean historical PE Ratio of Recce Pharmaceuticals Ltd over the last ten years is -8.71. The current -3.67 PE Ratio has changed 4.12% with respect to the historical average. Over the past ten years (40 quarters), RECEF's PE Ratio was at its highest in in the December 2015 quarter at -0.77. The PE Ratio was at its lowest in in the June 2015 quarter at -12.59.
Average
-8.71
Median
-7.80
Minimum
-19.74
Maximum
-2.91
Discovering the peaks and valleys of Recce Pharmaceuticals Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.81%
Maximum Annual PE Ratio = -2.91
Minimum Annual Increase = -86.80%
Minimum Annual PE Ratio = -19.74
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.21 | -46.69% |
| 2024 | -6.02 | -27.65% |
| 2023 | -8.32 | -41.01% |
| 2022 | -14.10 | 31.84% |
| 2021 | -10.69 | -45.83% |
| 2020 | -19.74 | 170.81% |
| 2019 | -7.29 | -24.04% |
| 2018 | -9.60 | 84.89% |
| 2017 | -5.19 | 78.69% |
| 2016 | -2.91 | -86.80% |
The current PE Ratio of Recce Pharmaceuticals Ltd (RECEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.85
5-year avg
-8.47
10-year avg
-8.71
Recce Pharmaceuticals Ltd’s PE Ratio is greater than Adocia S.A. (-4.26), less than Faron Pharmaceuticals Oy (-3.09), less than AnGes, Inc. (-3.40), less than Broncus Holding Corporation (-2.35), less than EKF Diagnostics Holdings plc (55.11), greater than Eupraxia Pharmaceuticals Inc. (-6.09), less than ACS Global, Inc. (0), greater than Prescient Therapeutics Limited (-6.73), greater than Adocia S.A. (-4.26), less than Planet 13 Holdings Inc. (-0.62),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.26 | $170.44M | |
| -3.09 | $209.54M | |
| -3.40 | $142.50M | |
| -2.35 | $42.13M | |
| 55.11 | $149.28M | |
| -6.09 | $108.29M | |
| 0 | $171.27M | |
| -6.73 | $117.53M | |
| -4.26 | $103.66M | |
| -0.62 | $202.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Recce Pharmaceuticals Ltd's PE Ratio?
How is the PE Ratio calculated for Recce Pharmaceuticals Ltd (RECEF)?
What is the highest PE Ratio for Recce Pharmaceuticals Ltd (RECEF)?
What is the 3-year average PE Ratio for Recce Pharmaceuticals Ltd (RECEF)?
What is the 5-year average PE Ratio for Recce Pharmaceuticals Ltd (RECEF)?
How does the current PE Ratio for Recce Pharmaceuticals Ltd (RECEF) compare to its historical average?